Paul K. Olson
Fondateur chez Kypha, Inc.
Profil
Paul K.
Olson is the founder of Kypha, Inc. founded in 2009, where he holds the title of President.
He previously worked as a Postdoctoral Fellow at Merck & Co., Inc. and as the Chief Scientific Officer at Potentia Pharmaceuticals, Inc. Dr. Olson received his undergraduate degree from the University of Wisconsin and his graduate degree from Robert Wood Johnson Medical School.
Postes actifs de Paul K. Olson
| Sociétés | Poste | Début |
|---|---|---|
Kypha, Inc.
 Kypha, Inc. Medical/Nursing ServicesHealth Services Kypha, Inc. engages in the development of devices and products to monitor and treat inflammatory and autoimmune disorders. Its products include Comp act, RapiPlex, and sample stabilization. The company was founded by Paul K. Olson and Chad M. Stiening on January 14, 2011 and is headquartered in St. Louis, MO. | Fondateur | 01/01/2009 |
Anciens postes connus de Paul K. Olson
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Potentia Pharmaceuticals, Inc.
 Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Directeur Technique/Scientifique/R&D | - |
Formation de Paul K. Olson
| University of Wisconsin | Undergraduate Degree |
| Robert Wood Johnson Medical School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Kypha, Inc.
Kypha, Inc. Medical/Nursing ServicesHealth Services Kypha, Inc. engages in the development of devices and products to monitor and treat inflammatory and autoimmune disorders. Its products include Comp act, RapiPlex, and sample stabilization. The company was founded by Paul K. Olson and Chad M. Stiening on January 14, 2011 and is headquartered in St. Louis, MO. | Health Services |
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Health Technology |
